iExposure Intervention for Social Anxiety

Launched by PALO ALTO UNIVERSITY · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people who have social anxiety, which is a common mental health issue that affects many individuals, especially young people. The trial is testing a program called iExposure, which aims to improve treatment for social anxiety by using personalized approaches. Researchers will compare the standard iExposure method with two other versions that focus on different ways of directing attention during treatment. This is important because many people with social anxiety do not receive the help they need, and the problem has increased since the COVID-19 pandemic.

To participate in this trial, you need to be at least 18 years old, speak English fluently, and have a specific level of social anxiety as measured by a questionnaire. Unfortunately, if you are currently receiving cognitive-behavioral therapy (CBT) for social anxiety, have significant vision problems, or have certain mental health issues, you may not be eligible. If you join the study, you can expect to engage in online sessions aimed at reducing your social anxiety, with the support of researchers who will guide you through the process. This trial is a great opportunity for those looking for effective treatment options for social anxiety.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 or older
• • Fluent in English
• • Leibowitz Social Anxiety Scale \> 47 and endorses both social anxiety items on the Web Screening Questionnaire for Common Mental Disorders
• Exclusion Criteria:
• • Currently receiving CBT for Social Anxiety Disorder
• • Significant visual impairment precluding engagement in the simulated teleconferencing interactions
• • Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment
• • Current alcohol or substance use disorder
• • Current or past bipolar disorder or psychosis